Affected Systems |
|
|
|
|
cellular
|
√
|
√
|
√
|
increased B cell apoptosis
|
|
|
√
|
abnormal osteoblast differentiation
|
√
|
|
|
abnormal B cell proliferation
|
|
|
√
|
increased B cell proliferation
|
|
√
|
|
endocrine/exocrine glands
|
|
√
|
|
abnormal pancreatic beta cell morphology
|
|
√
|
|
decreased insulin secretion
|
|
√
|
|
growth/size/body
|
|
√
|
|
decreased body weight
|
|
√
|
|
enlarged spleen
|
|
√
|
|
hematopoietic system
|
|
√
|
√
|
increased B cell apoptosis
|
|
|
√
|
abnormal B cell proliferation
|
|
|
√
|
increased B cell proliferation
|
|
√
|
|
enlarged spleen
|
|
√
|
|
abnormal plasma cell differentiation
|
|
√
|
√
|
arrested B cell differentiation
|
|
|
√
|
decreased B-1 B cell number
|
|
|
√
|
decreased B-2 B cell number
|
|
|
√
|
decreased follicular B cell number
|
|
|
√
|
decreased marginal zone B cell number
|
|
|
√
|
increased B cell number
|
|
√
|
|
increased transitional stage B cell number
|
|
√
|
|
increased follicular B cell number
|
|
√
|
|
increased marginal zone B cell number
|
|
√
|
|
increased spleen germinal center number
|
|
√
|
|
abnormal immunoglobulin level
|
|
√
|
√
|
increased IgA level
|
|
√
|
√
|
increased IgG1 level
|
|
√
|
√
|
increased IgG2b level
|
|
|
√
|
increased IgG3 level
|
|
|
√
|
increased IgM level
|
|
√
|
√
|
homeostasis/metabolism
|
|
√
|
|
decreased insulin secretion
|
|
√
|
|
impaired glucose tolerance
|
|
√
|
|
immune system
|
|
√
|
√
|
increased B cell apoptosis
|
|
|
√
|
abnormal B cell proliferation
|
|
|
√
|
increased B cell proliferation
|
|
√
|
|
enlarged spleen
|
|
√
|
|
abnormal plasma cell differentiation
|
|
√
|
√
|
arrested B cell differentiation
|
|
|
√
|
decreased B-1 B cell number
|
|
|
√
|
decreased B-2 B cell number
|
|
|
√
|
decreased follicular B cell number
|
|
|
√
|
decreased marginal zone B cell number
|
|
|
√
|
increased B cell number
|
|
√
|
|
increased transitional stage B cell number
|
|
√
|
|
increased follicular B cell number
|
|
√
|
|
increased marginal zone B cell number
|
|
√
|
|
increased spleen germinal center number
|
|
√
|
|
abnormal immunoglobulin level
|
|
√
|
√
|
increased IgA level
|
|
√
|
√
|
increased IgG1 level
|
|
√
|
√
|
increased IgG2b level
|
|
|
√
|
increased IgG3 level
|
|
|
√
|
increased IgM level
|
|
√
|
√
|
abnormal Peyer's patch germinal center morphology
|
|
√
|
|
abnormal lymph node germinal center morphology
|
|
√
|
|
enlarged lymph nodes
|
|
√
|
|
increased interleukin-6 secretion
|
|
√
|
|
increased anti-chromatin antibody level
|
|
√
|
|
increased acute inflammation
|
|
√
|
|
glomerulonephritis
|
|
√
|
|
renal/urinary system
|
|
√
|
|
glomerulonephritis
|
|
√
|
|
renal glomerular immunoglobulin deposits
|
|
√
|
|
skeleton
|
√
|
|
|
abnormal osteoblast differentiation
|
√
|
|
|
decreased width of hypertrophic chondrocyte zone
|
√
|
|
|
abnormal bone ossification
|
√
|
|
|